These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 11916908)

  • 21. Glucose transport rate and glycogen synthase activity both limit skeletal muscle glycogen accumulation.
    Fisher JS; Nolte LA; Kawanaka K; Han DH; Jones TE; Holloszy JO
    Am J Physiol Endocrinol Metab; 2002 Jun; 282(6):E1214-21. PubMed ID: 12006350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of tumor necrosis factor-alpha on glucose metabolism in cultured human muscle cells from nondiabetic and type 2 diabetic subjects.
    Ciaraldi TP; Carter L; Mudaliar S; Kern PA; Henry RR
    Endocrinology; 1998 Dec; 139(12):4793-800. PubMed ID: 9832415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes.
    Nikoulina SE; Ciaraldi TP; Mudaliar S; Mohideen P; Carter L; Henry RR
    Diabetes; 2000 Feb; 49(2):263-71. PubMed ID: 10868943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased insulin responsiveness of glucose uptake in cultured human skeletal muscle cells from insulin-resistant nondiabetic relatives of type 2 diabetic families.
    Jackson S; Bagstaff SM; Lynn S; Yeaman SJ; Turnbull DM; Walker M
    Diabetes; 2000 Jul; 49(7):1169-77. PubMed ID: 10909975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epinephrine-stimulated glycogen breakdown activates glycogen synthase and increases insulin-stimulated glucose uptake in epitrochlearis muscles.
    Kolnes AJ; Birk JB; Eilertsen E; Stuenæs JT; Wojtaszewski JF; Jensen J
    Am J Physiol Endocrinol Metab; 2015 Feb; 308(3):E231-40. PubMed ID: 25465888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracellular defects in glucose metabolism in obese patients with NIDDM.
    Kelley DE; Mokan M; Mandarino LJ
    Diabetes; 1992 Jun; 41(6):698-706. PubMed ID: 1587397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased phosphorylation of skeletal muscle glycogen synthase at NH2-terminal sites during physiological hyperinsulinemia in type 2 diabetes.
    Højlund K; Staehr P; Hansen BF; Green KA; Hardie DG; Richter EA; Beck-Nielsen H; Wojtaszewski JF
    Diabetes; 2003 Jun; 52(6):1393-402. PubMed ID: 12765949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperglycaemia compensates for the defects in insulin-mediated glucose metabolism and in the activation of glycogen synthase in the skeletal muscle of patients with type 2 (non-insulin-dependent) diabetes mellitus.
    Vaag A; Damsbo P; Hother-Nielsen O; Beck-Nielsen H
    Diabetologia; 1992 Jan; 35(1):80-8. PubMed ID: 1541385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of insulin resistance in non-oxidative glucose metabolism: the role of glycogen synthase.
    Beck-Nielsen H
    J Basic Clin Physiol Pharmacol; 1998; 9(2-4):255-79. PubMed ID: 10212838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracellular skeletal muscle glucose metabolism is differentially altered by dexamethasone treatment of normoglycemic relatives of type 2 diabetic patients.
    Henriksen JE; Alford F; Vaag A; Handberg A; Beck-Nielsen H
    Metabolism; 1999 Sep; 48(9):1128-35. PubMed ID: 10484052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of glycogen synthase kinase 3 improves insulin action and glucose metabolism in human skeletal muscle.
    Nikoulina SE; Ciaraldi TP; Mudaliar S; Carter L; Johnson K; Henry RR
    Diabetes; 2002 Jul; 51(7):2190-8. PubMed ID: 12086949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physiological hyperinsulinemia impairs insulin-stimulated glycogen synthase activity and glycogen synthesis.
    Iozzo P; Pratipanawatr T; Pijl H; Vogt C; Kumar V; Pipek R; Matsuda M; Mandarino LJ; Cusi KJ; DeFronzo RA
    Am J Physiol Endocrinol Metab; 2001 May; 280(5):E712-9. PubMed ID: 11287353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The reduced insulin-mediated glucose oxidation in skeletal muscle from type 2 diabetic subjects may be of genetic origin--evidence from cultured myotubes.
    Gaster M; Beck-Nielsen H
    Biochim Biophys Acta; 2004 Sep; 1690(1):85-91. PubMed ID: 15337174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abnormal glucose transport and GLUT1 cell-surface content in fibroblasts and skeletal muscle from NIDDM and obese subjects.
    Miele C; Formisano P; Condorelli G; Caruso M; Oriente F; Andreozzi F; Tocchetti CG; Riccardi G; Beguinot F
    Diabetologia; 1997 Apr; 40(4):421-9. PubMed ID: 9112019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The basal kinetic parameters of glycogen synthase in human myotube cultures are not affected by chronic high insulin exposure.
    Gaster M; Schrøder HD; Handberg A; Beck-Nielsen H
    Biochim Biophys Acta; 2001 Nov; 1537(3):211-21. PubMed ID: 11731223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperglycemia markedly enhances skeletal muscle glycogen synthase activity in diabetic, but not in normal conscious rats.
    Farrace S; Rossetti L
    Diabetes; 1992 Nov; 41(11):1453-63. PubMed ID: 1397721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients.
    Krook A; Björnholm M; Galuska D; Jiang XJ; Fahlman R; Myers MG; Wallberg-Henriksson H; Zierath JR
    Diabetes; 2000 Feb; 49(2):284-92. PubMed ID: 10868945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperglycaemia normalises insulin action on glucose metabolism but not the impaired activation of AKT and glycogen synthase in the skeletal muscle of patients with type 2 diabetes.
    Vind BF; Birk JB; Vienberg SG; Andersen B; Beck-Nielsen H; Wojtaszewski JF; Højlund K
    Diabetologia; 2012 May; 55(5):1435-45. PubMed ID: 22322917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes.
    Cline GW; Petersen KF; Krssak M; Shen J; Hundal RS; Trajanoski Z; Inzucchi S; Dresner A; Rothman DL; Shulman GI
    N Engl J Med; 1999 Jul; 341(4):240-6. PubMed ID: 10413736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple defects in muscle glycogen synthase activity contribute to reduced glycogen synthesis in non-insulin dependent diabetes mellitus.
    Thorburn AW; Gumbiner B; Bulacan F; Brechtel G; Henry RR
    J Clin Invest; 1991 Feb; 87(2):489-95. PubMed ID: 1899428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.